Regulation of cellular innate antiviral signaling by ubiquitin modification

Acta Biochimica et Biophysica Sinica

Volumn 47, Issue 3, 2015, Pages 149-155

  Lin, Dandan ^a   Zhong, Bo ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Cellular innate antiviral signaling; Pattern recognition receptor; Ubiquitin modification

Indexed keywords

DEUBIQUITINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; IRF3 PROTEIN, HUMAN; PATHOGEN ASSOCIATED MOLECULAR PATTERN; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR;

CELLULAR IMMUNITY; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; PATHOGENICITY; PHYSIOLOGY; SIGNAL TRANSDUCTION; UBIQUITINATION; VIRUS;

HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, INNATE; INTERFERON REGULATORY FACTOR-3; NF-KAPPA B; PATHOGEN-ASSOCIATED MOLECULAR PATTERN MOLECULES; RECEPTORS, PATTERN RECOGNITION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; UBIQUITIN-SPECIFIC PROTEASES; UBIQUITINATION; VIRUSES;

EID: 84941559613     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmu133     Document Type: Review

References (102)

1. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140: 805-820.
2. Sadler AJ, Williams BR. Interferon-inducible antiviral effectors. Nat Rev Immunol 2008, 8: 559-568.
3. Hacker H, Vabulas RM, Takeuchi O, Hoshino K, Akira S, Wagner H. Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF) 6. J Exp Med 2000, 192: 595-600.
4. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000, 408: 740-745.
5. Schnare M, Holt AC, Takeda K, Akira S, Medzhitov R. Recognition of CpG DNA is mediated by signaling pathways dependent on the adaptor protein MyD88. Curr Biol 2000, 10: 1139-1142.
6. Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, Takeuchi O, et al. Role of adaptor TRIF in the MyD88-independent tolllike receptor signaling pathway. Science 2003, 301: 640-643.
7. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001, 413: 732-738.
8. Hemmi H, Kaisho T, Takeuchi O, Sato S, Sanjo H, Hoshino K, Horiuchi T, et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 2002, 3: 196-200.
9. Andrejeva J, Childs KS, Young DF, Carlos TS, Stock N, Goodbourn S, Randall RE. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci USA 2004, 101: 17264-17269.
10. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004, 5: 730-737.
11. Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, Ishii KJ, et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 2005, 6: 981-988.
12. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, Bartenschlager R, Tschopp J. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 2005, 437: 1167-1172.
13. Seth RB, Sun L, Ea CK, Chen ZJ. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 2005, 122: 669-682.
14. Xu LG, Wang YY, Han KJ, Li LY, Zhai Z, Shu HB. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 2005, 19: 727-740.
15. Ishikawa H, Barber GN. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 2008, 455: 674-678.
16. Zhong B, Yang Y, Li S, Wang YY, Li Y, Diao F, Lei C, et al. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity 2008, 29: 538-550.
17. Sun L, Wu J, Du F, Chen X, Chen ZJ. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 2013, 339: 786-791.
18. Ablasser A, Bauernfeind F, Hartmann G, Latz E, Fitzgerald KA, Hornung V. RIG-I-dependent sensing of poly (dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat Immunol 2009, 10: 1065-1072.
19. Chiu YH, Macmillan JB, Chen ZJ. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway.Cell 2009, 138: 576-591.
20. Unterholzner L, Keating SE, Baran M, Horan KA, Jensen SB, Sharma S, Sirois CM, et al. IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol 2010, 11: 997-1004.
21. Parvatiyar K, Zhang Z, Teles RM, Ouyang S, Jiang Y, Iyer SS, Zaver SA, et al. The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune response. Nat Immunol 2012, 13: 1155-1161.
22. Li Y, Chen R, Zhou Q, Xu Z, Li C, Wang S, Mao A, et al. LSm14A is a processing body-associated sensor of viral nucleic acids that initiates cellular antiviral response in the early phase of viral infection. Proc Natl Acad Sci USA 2012, 109: 11770-11775.
23. Takaoka A, Wang Z, Choi MK, Yanai H, Negishi H, Ban T, Lu Y, et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 2007, 448: 501-505.
24. Hemmi H, Takeuchi O, Sato S, Yamamoto M, Kaisho T, Sanjo H, Kawai T, et al. The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection. J Exp Med 2004, 199: 1641-1650.
25. Perry AK, Chow EK, Goodnough JB, Yeh WC, Cheng G. Differential requirement for TANK-binding kinase-1 in type I interferon responses to toll-like receptor activation and viral infection. J Exp Med 2004, 199: 1651-1658.
26. Long L, Deng Y, Yao F, Guan D, Feng Y, Jiang H, Li X, et al. Recruitment of phosphatase PP2A by RACK1 adaptor protein deactivates transcription factor IRF3 and limits type I interferon signaling. Immunity 2014, 40: 515-529.
27. Nijman SM, Luna-Vargas MP, Velds A, Brummelkamp TR, Dirac AM, Sixma TK, Bernards R. A genomic and functional inventory of deubiquitinating enzymes. Cell 2005, 123: 773-786.
28. Komander D, Clague MJ, Urbe S. Breaking the chains: Structure and function of the deubiquitinases. Nat Rev Mol Cell Biol 2009, 10: 550-563.
29. Hacker H, Redecke V, Blagoev B, Kratchmarova I, Hsu LC, Wang GG, Kamps MP, et al. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 2006, 439: 204-207.
30. Oganesyan G, Saha SK, Guo B, He JQ, Shahangian A, Zarnegar B, Perry A, et al. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 2006, 439: 208-211.
31. Chuang TH, Ulevitch RJ. Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors. Nat Immunol 2004, 5: 495-502.
32. Mao AP, Li S, Zhong B, Li Y, Yan J, Li Q, Teng C, et al. Virus-triggered ubiquitination of TRAF3/6 by cIAP1/2 is essential for induction of interferon-beta (IFN-beta) and cellular antiviral response. J Biol Chem 2010, 285: 9470-9476.
33. Chang M, JinW, Sun SC. Peli1 facilitates TRIF-dependent Toll-like receptor signaling and proinflammatory cytokine production. Nat Immunol 2009, 10: 1089-1095.
34. Yang Y, Liao B, Wang S, Yan B, Jin Y, Shu HB, Wang YY. E3 ligase WWP2 negatively regulates TLR3-mediated innate immune response by targeting TRIF for ubiquitination and degradation. Proc Natl Acad Sci USA 2013, 110: 5115-5120.
35. Xue Q, Zhou Z, Lei X, Liu X, He B,Wang J, Hung T. TRIM38 negatively regulates TLR3-mediated IFN-beta signaling by targeting TRIF for degradation. PLoS One 2012, 7: E46825.
36. Wang C, Chen T, Zhang J, Yang M, Li N, Xu X, Cao X. The E3 ubiquitin ligase Nrdp1 'preferentially' promotes TLR-mediated production of type I interferon. Nat Immunol 2009, 10: 744-752.
37. Myong S, Cui S, Cornish PV, Kirchhofer A, Gack MU, Jung JU, Hopfner KP, et al. Cytosolic viral sensor RIG-I is a 5'-triphosphate-dependent translocase on double-stranded RNA. Science 2009, 323: 1070-1074.
38. Nallagatla SR, Hwang J, Toroney R, Zheng X, Cameron CE, Bevilacqua PC. 5'-Triphosphate-dependent activation of PKR by RNAs with short stem-loops. Science 2007, 318: 1455-1458.
39. Hornung V, Ellegast J, Kim S, Brzozka K, Jung A, Kato H, Poeck H, et al. 5'-Triphosphate RNA is the ligand for RIG-I. Science 2006, 314: 994-997.
40. Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, Weber F, Reis e Sousa C. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science 2006, 314: 997-1001.
41. Schlee M, Roth A, Hornung V, Hagmann CA, Wimmenauer V, BarchetW, Coch C, et al. Recognition of 5' triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity 2009, 31: 25-34.
42. Kato H, Takeuchi O, Mikamo-Satoh E, Hirai R, Kawai T, Matsushita K, Hiiragi A, et al. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med 2008, 205: 1601-1610.
43. Satoh T, Kato H, Kumagai Y, Yoneyama M, Sato S, Matsushita K, Tsujimura T, et al. LGP2 is a positive regulator of RIG-I- and MDA5- mediated antiviral responses. Proc Natl Acad Sci USA 2010, 107: 1512-1517.
44. Gack MU, Shin YC, Joo CH, Urano T, Liang C, Sun L, Takeuchi O, et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 2007, 446: 916-920.
45. Oshiumi H, Miyashita M, Inoue N, Okabe M, Matsumoto M, Seya T. The ubiquitin ligase Riplet is essential for RIG-I-dependent innate immune responses to RNA virus infection. Cell Host Microbe 2010, 8: 496-509.
46. Gao D, Yang YK, Wang RP, Zhou X, Diao FC, Li MD, Zhai ZH, et al. REUL is a novel E3 ubiquitin ligase and stimulator of retinoic-acid-inducible gene-I. PLoS One 2009, 4: E5760.
47. Yan J, Li Q, Mao AP, Hu MM, Shu HB. TRIM4 modulates type I interferon induction and cellular antiviral response by targeting RIG-I for K63-linked ubiquitination. J Mol Cell Biol 2014, 6: 154-163.
48. Kuniyoshi K, Takeuchi O, Pandey S, Satoh T, Iwasaki H, Akira S, Kawai T. Pivotal role of RNA-binding E3 ubiquitin ligase MEX3C in RIG-I-mediated antiviral innate immunity. Proc Natl Acad Sci USA 2014, 111: 5646-5651.
49. ZengW, Sun L, Jiang X, Chen X, Hou F, Adhikari A, Xu M, et al. Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell 2010, 141: 315-330.
50. Arimoto K, Takahashi H, Hishiki T, Konishi H, Fujita T, Shimotohno K. Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125. Proc Natl Acad Sci USA 2007, 104: 7500-7505.
51. Chen W, Han C, Xie B, Hu X, Yu Q, Shi L, Wang Q, et al. Induction of Siglec-G by RNA viruses inhibits the innate immune response by promoting RIG-I degradation. Cell 2013, 152: 467-478.
52. Das A, Dinh PX, Panda D, Pattnaik AK. Interferon-inducible protein IFI35 negatively regulates RIG-I antiviral signaling and supports vesicular stomatitis virus replication. J Virol 2014, 88: 3103-3113.
53. Hou F, Sun L, Zheng H, Skaug B, Jiang QX, Chen ZJ. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 2011, 146: 448-461.
54. Paz S, Vilasco M, Arguello M, Sun Q, Lacoste J, Nguyen TL, Zhao T, et al. Ubiquitin-regulated recruitment of IkappaB kinase epsilon to the MAVS interferon signaling adapter. Mol Cell Biol 2009, 29: 3401-3412.
55. Castanier C, Zemirli N, Portier A, Garcin D, Bidere N, Vazquez A, Arnoult D. MAVS ubiquitination by the E3 ligase TRIM25 and degradation by the proteasome is involved in type I interferon production after activation of the antiviral RIG-I-like receptors. BMC Biol 2012, 10: 44.
56. Zhong B, Zhang Y, Tan B, Liu TT, Wang YY, Shu HB. The E3 ubiquitin ligase RNF5 targets virus-induced signaling adaptor for ubiquitination and degradation. J Immunol 2010, 184: 6249-6255.
57. You F, Sun H, Zhou X, SunW, Liang S, Zhai Z, Jiang Z. PCBP2 mediates degradation of the adaptor MAVS via the HECT ubiquitin ligase AIP4. Nat Immunol 2009, 10: 1300-1308.
58. Jia Y, Song T, Wei C, Ni C, Zheng Z, Xu Q, Ma H, et al. Negative regulation of MAVS-mediated innate immune response by PSMA7. J Immunol 2009, 183: 4241-4248.
59. Wang Y, Tong X, Ye X. Ndfip1 negatively regulates RIG-I-dependent immune signaling by enhancing E3 ligase Smurf1-mediated MAVS degradation. J Immunol 2012, 189: 5304-5313.
60. Pan Y, Li R, Meng JL, Mao HT, Zhang Y, Zhang J. Smurf2 negatively modulates RIG-I-dependent antiviral response by targeting VISA/MAVS for ubiquitination and degradation. J Immunol 2014, 192: 4758-4764.
61. Liu S, Chen J, Cai X, Wu J, Chen X, Wu YT, Sun L, et al. MAVS recruits multiple ubiquitin E3 ligases to activate antiviral signaling cascades. Elife 2013, 2: E00785.
62. Nakhaei P, Mesplede T, Solis M, Sun Q, Zhao T, Yang L, Chuang TH, et al. The E3 ubiquitin ligase Triad3A negatively regulates the RIG-I/ MAVS signaling pathway by targeting TRAF3 for degradation. PLoS Pathog 2009, 5: E1000650.
63. Fang DF,He K,Wang J, Mu R, Tan B, Jian Z, LiHY, et al. RAD23A negatively regulates RIG-I/MDA5 signaling through promoting TRAF2 polyubiquitination and degradation. Biochem Biophys Res Commun 2013, 431: 686-692.
64. Ye JS, Kim N, Lee KJ, Nam YR, Lee U, Joo CH. Lysine 63-linked TANKbinding kinase 1 ubiquitination by mindbomb E3 ubiquitin protein ligase 2 is mediated by the mitochondrial antiviral signaling protein. J Virol 2014, 88: 12765-12776.
65. Zhang M, Wang L, Zhao X, Zhao K, Meng H, Zhao W, Gao C. TRAF-interacting protein (TRIP) negatively regulates IFN-beta production and antiviral response by promoting proteasomal degradation of TANK-binding kinase 1. J Exp Med 2012, 209: 1703-1711.
66. Cui J, Li Y, Zhu L, Liu D, Songyang Z,WangHY,Wang RF. NLRP4 negatively regulates type I interferon signaling by targeting the kinase TBK1 for degradation via the ubiquitin ligase DTX4. Nat Immunol 2012, 13: 387-395.
67. Belgnaoui SM, Paz S, Samuel S, Goulet ML, Sun Q, Kikkert M, Iwai K, et al. Linear ubiquitination of NEMO negatively regulates the interferon antiviral response through disruption of the MAVS-TRAF3 complex. Cell Host Microbe 2012, 12: 211-222.
68. Inn KS, Gack MU, Tokunaga F, Shi M,Wong LY, Iwai K, Jung JU. Linear ubiquitin assembly complex negatively regulates RIG-I- and TRIM25- mediated type I interferon induction. Mol Cell 2011, 41: 354-365.
69. Zhang M, Tian Y, Wang RP, Gao D, Zhang Y, Diao FC, Chen DY, et al. Negative feedback regulation of cellular antiviral signaling by RBCK1-mediated degradation of IRF3. Cell Res 2008, 18: 1096-1104.
70. Lei CQ, Zhang Y, Xia T, Jiang LQ, Zhong B, Shu HB. FoxO1 negatively regulates cellular antiviral response by promoting degradation of IRF3. J Biol Chem 2013, 288: 12596-12604.
71. Yu Y, Hayward GS. The ubiquitin E3 ligase RAUL negatively regulates type i interferon through ubiquitination of the transcription factors IRF7 and IRF3. Immunity 2010, 33: 863-877.
72. Zheng D, Chen G, Guo B, Cheng G, Tang H. PLP2, a potent deubiquitinase from murine hepatitis virus, strongly inhibits cellular type I interferon production. Cell Res 2008, 18: 1105-1113.
73. Cai X, Chiu YH, Chen ZJ. The cGAS-cGAMP-STING pathway of cytosolic DNA sensing and signaling. Mol Cell 2014, 54: 289-296.
74. Wu J, Sun L, Chen X, Du F, Shi H, Chen C, Chen ZJ. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 2013, 339: 826-830.
75. Tsuchida T, Zou J, Saitoh T, Kumar H, Abe T, Matsuura Y, Kawai T, et al. The ubiquitin ligase TRIM56 regulates innate immune responses to intracellular double-stranded DNA. Immunity 2010, 33: 765-776.
76. Zhang J, Hu MM, Wang YY, Shu HB. TRIM32 protein modulates type I interferon induction and cellular antiviral response by targeting MITA/ STING protein for K63-linked ubiquitination. J Biol Chem 2012, 287: 28646-28655.
77. Zhong B, Zhang L, Lei C, Li Y, Mao AP, Yang Y, Wang YY, et al. The ubiquitin ligase RNF5 regulates antiviral responses by mediating degradation of the adaptor protein MITA. Immunity 2009, 30: 397-407.
78. Qin Y, Zhou MT, Hu MM, Hu YH, Zhang J, Guo L, Zhong B, et al. RNF26 temporally regulates virus-triggered type I interferon induction by two distinct mechanisms. PLoS Pathog 2014, 10: E1004358.
79. Zhang Z, Bao M, Lu N, Weng L, Yuan B, Liu YJ. The E3 ubiquitin ligase TRIM21 negatively regulates the innate immune response to intracellular double-stranded DNA. Nat Immunol 2013, 14: 172-178.
80. Zhang M, Wu X, Lee AJ, Jin W, Chang M, Wright A, Imaizumi T, et al. Regulation of IkappaB kinase-related kinases and antiviral responses by tumor suppressor CYLD. J Biol Chem 2008, 283: 18621-18626.
81. Chen R, Zhang L, Zhong B, Tan B, Liu Y, Shu HB. The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. Cell Res 2010, 20: 802-811.
82. Pauli EK, Chan YK, Davis ME, Gableske S, Wang MK, Feister KF, Gack MU. The ubiquitin-specific protease USP15 promotes RIG-Imediated antiviral signaling by deubiquitylating TRIM25. Sci Signal 2014, 7: Ra3.
83. Wang L, Zhao W, Zhang M, Wang P, Zhao K, Zhao X, Yang S, et al. USP4 positively regulates RIG-I-mediated antiviral response through deubiquitination and stablilization of RIG-I. J Virol 2013, 87: 4507-4515.
84. Cui J, Song Y, Li Y, Zhu Q, Tan P, Qin Y, Wang HY, et al. USP3 inhibits type I interferon signaling by deubiquitinating RIG-I-like receptors. Cell Res 2014, 24: 400-416.
85. Fan Y, Mao R, Yu Y, Liu S, Shi Z, Cheng J, Zhang H, et al. USP21 negatively regulates antiviral response by acting as a RIG-I deubiquitinase. J Exp Med 2014, 211: 313-328.
86. van Kasteren PB, Beugeling C, Ninaber DK, Frias-Staheli N, van Boheemen S, Garcia-Sastre A, Snijder EJ, et al. Arterivirus and Nairovirus ovarian tumor domain-containing deubiquitinases target activated RIG-I to control innate immune signaling. J Virol 2012, 86: 773-785.
87. Inn KS, Lee SH, Rathbun JY,Wong LY, Toth Z, Machida K, Ou JH, et al. Inhibition of RIG-I-mediated signaling by Kaposi's sarcoma-associated herpesvirus-encoded deubiquitinase ORF64. J Virol 2011, 85: 10899-10904.
88. Wang D, Fang L, Li P, Sun L, Fan J, Zhang Q, Luo R, et al. The leader proteinase of foot-and-mouth disease virus negatively regulates the type I interferon pathway by acting as a viral deubiquitinase. J Virol 2011, 85: 3758-3766.
89. Nan Y, Yu Y, Ma Z, Khattar SK, Fredericksen B, Zhang YJ. Hepatitis E virus inhibits type I interferon induction by ORF1 products. J Virol 2014, 88: 11924-11932.
90. Luo H, Zhang Z, Zheng Z, Ke X, Zhang X, Li Q, Liu Y, et al. Human bocavirus VP2 upregulates IFN-beta pathway by inhibiting ring finger protein 125-mediated ubiquitination of retinoic acid-inducible gene-I. J Immunol 2013, 191: 660-669.
91. Now H, Yoo JY. A protein-kinase, IFN-inducible double-stranded RNA dependent inhibitor and repressor of p58 (PRKRIR) enhances type I IFNmediated antiviral response through the stability control of RIG-I protein. Biochem Biophys Res Commun 2011, 413: 487-493.
92. Rajsbaum R, Albrecht RA, Wang MK, Maharaj NP, Versteeg GA, Nistal-Villan E, García-Sastre A, et al. Species-specific inhibition of RIG-I ubiquitination and IFN induction by the influenza Avirus NS1 protein. PLoS Pathog 2012, 8: E1003059.
93. Kayagaki N, Phung Q, Chan S, Chaudhari R, Quan C, O'Rourke KM, Eby M, et al. DUBA: A deubiquitinase that regulates type I interferon production. Science 2007, 318: 1628-1632.
94. Li S, Zheng H, Mao AP, Zhong B, Li Y, Liu Y, Gao Y, et al. Regulation of virus-triggered signaling by OTUB1- and OTUB2-mediated deubiquitination of TRAF3 and TRAF6. J Biol Chem 2010, 285: 4291-4297.
95. Saito S, Murata T, Kanda T, Isomura H, Narita Y, Sugimoto A, Kawashima D, et al. Epstein-Barr virus deubiquitinase downregulates TRAF6-mediated NF-kappaB signaling during productive replication. J Virol 2013, 87: 4060-4070.
96. Chen ZJ. Ubiquitination in signaling to and activation of IKK. Immunol Rev 2012, 246: 95-106.
97. Charoenthongtrakul S, Gao L, Parvatiyar K, Lee D, HarhajEW. RING finger protein 11 targets TBK1/IKKi kinases to inhibit antiviral signaling. PLoS One 2013, 8: E53717.
98. Wang G, Chen G, Zheng D, Cheng G, Tang H. PLP2 of mouse hepatitis virus A59 (MHV-A59) targets TBK1 to negatively regulate cellular type I interferon signaling pathway. PLoS One 2011, 6: E17192.
99. Ran Y, Liu TT, Zhou Q, Li S, Mao AP, Li Y, Liu LJ, et al. SENP2 negatively regulates cellular antiviral response by deSUMOylating IRF3 and conditioning it for ubiquitination and degradation. J Mol Cell Biol 2011, 3: 283-292.
100. Mi Z, Fu J, Xiong Y, Tang H. SUMOylation of RIG-I positively regulates the type I interferon signaling. Protein Cell 2010, 1: 275-283.
101. Fu J, Xiong Y, Xu Y, Cheng G, Tang H. MDA5 is SUMOylated by PIAS2- beta in the upregulation of type I interferon signaling. Mol Immunol 2011, 48: 415-422.
102. Arimoto K, Konishi H, Shimotohno K. UbcH8 regulates ubiquitin and ISG15 conjugation to RIG-I. Mol Immunol 2008, 45: 1078-1084.